Wampole Labs
This article was originally published in The Gray Sheet
Executive Summary
Carter-Wallace division launches PreVue B. burgdorferi antibody detection assay June 16. Test kits are being marketed to physician offices and clinical labs through a network of distributors. The 20 minute point of care test for Lyme disease, which uses recombinant antigens for the detection of IgG and IgM immunoglobulins to B. burgdorferi, sells for about $10 each - $200 for 20 tests